| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/09/2005 | EP1503681A1 Magnetic embryo transfer |
| 02/09/2005 | EP1503652A2 Vascularization enhanced graft constructs |
| 02/09/2005 | EP1503625A1 Vascularization enhanced graft constructs |
| 02/09/2005 | EP1456223A4 Rapidly maturing fluorescent proteins and methods for using the same |
| 02/09/2005 | EP1313885A4 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 02/09/2005 | EP1255850A4 AMPLIFICATION OF $i(CYP24) AND USES THEREOF |
| 02/09/2005 | EP1109888A4 Enhanced submucosal tissue graft constructs |
| 02/09/2005 | EP1079772B1 Corporal tissue penile reconstruction |
| 02/09/2005 | EP1051427A4 Spoil protein and nucleic acid molecules and uses therefor |
| 02/09/2005 | EP1017805B1 Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof |
| 02/09/2005 | EP1009805A4 TRANSGENIC PLANTS OF ALTERED MORPHOLOGY AND THE ISOLATED $i(ARABIDOPSIS THALIANA) ENDO-1,4-$g(b)-GLUCANASE GENE, PROMOTER AND PROTEIN |
| 02/09/2005 | EP0843818B1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 02/09/2005 | EP0700438B1 Opioid receptors: compositions and methods |
| 02/09/2005 | EP0365597B2 Improved processes for the treatment of vascular disease |
| 02/09/2005 | CN1578838A Method and means for producing protein with prospective post-translation modification |
| 02/09/2005 | CN1578837A Regulated nucleic acid expression system |
| 02/09/2005 | CN1578836A Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 02/09/2005 | CN1578832A Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants |
| 02/09/2005 | CN1578830A A unit and a process for carrying out high cell density fermentation |
| 02/09/2005 | CN1578785A Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 02/09/2005 | CN1578678A Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/09/2005 | CN1576779A Method and system for three-dimensionally imaging an apical dome of a plant |
| 02/09/2005 | CN1576369A Prawn leukasmus rhabdovirus dUTPase gene and coded polypeptide thereof |
| 02/09/2005 | CN1576368A Prawn leukasmus rhabdovirus VP26 gene correlated with infection and coded polypeptide thereof |
| 02/09/2005 | CN1576367A Prawn leukasmus rhabdovirus WP486 gene and coded polypeptide thereof |
| 02/09/2005 | CN1576365A 葡萄糖脱氢酶 Glucose dehydrogenase |
| 02/09/2005 | CN1576364A Building identification and application for heterogenic interbone marrow filling stem cell transplantation chimeric model |
| 02/09/2005 | CN1576363A Methods and compositions for regrowth of cryopreserved conifer embryos |
| 02/09/2005 | CN1575645A Method and system for simultaneously imaging multiple views of a plant embryo |
| 02/09/2005 | CN1188528C Intercellular adhesion molecule-3 and its binding ligands |
| 02/09/2005 | CN1188525C Improved i (agrobacterium)-mediated transformation of plants |
| 02/09/2005 | CN1188426C Antibodise against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 02/09/2005 | CN1188172C G-CSF conjugates |
| 02/09/2005 | CN1188027C Cytoplasmic male sterile brassica oleracea plant, and method for obtaining such plant |
| 02/08/2005 | US6852913 Combines in a single variety an improved combination of desirable traits from the parental germplasm such as higher seed yield, resistance to diseases and insects, tolerance to drought and heat, and better agronomic qualities |
| 02/08/2005 | US6852851 DNA isolation method |
| 02/08/2005 | US6852848 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 02/08/2005 | US6852846 Viral amplification of recombinant messenger RNA in transgenic plants |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852838 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders |
| 02/08/2005 | US6852837 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 02/08/2005 | US6852835 DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses |
| 02/08/2005 | US6852537 Transgenic circulating endothelial cells |
| 02/08/2005 | US6852534 Method to determine an engrafting cell dose of hematopoietic stem cell transplant units |
| 02/08/2005 | US6852533 For making vectors for gene therapy |
| 02/08/2005 | US6852532 Isolating human nervous system tissue from fetal tissue; obtain human fetal cells, culture, immunodeplete, isolate nervous system tissue |
| 02/08/2005 | US6852531 Compositions and methods for reproducing and modulating mammalian messenger RNA decapping |
| 02/08/2005 | US6852529 Gloucose-regulated mRNA instability element |
| 02/08/2005 | US6852528 Human and mouse uroplakin II gene transcriptional regulatory elements |
| 02/08/2005 | US6852520 DSP-2 dual-specificity phosphatase |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852497 Fusion protein |
| 02/08/2005 | US6852486 Detection of leukocyte antigen in sample; obtain cell sample, incubate with bindng protein, detect bound protein, presence of bound protein indicates leukocyte antigen presence |
| 02/08/2005 | US6852331 Embedding cells in three-dimensional structure |
| 02/08/2005 | US6852322 Surface proteins of Leptospira |
| 02/08/2005 | US6852321 Lectin-derived progenitor cell preservation factor and methods of use |
| 02/08/2005 | CA2323726C Control of gene expression |
| 02/08/2005 | CA2278588C Method for increasing the growth of plant cell cultures |
| 02/08/2005 | CA2184183C Inhibin compositions and methods of use thereof |
| 02/08/2005 | CA2110933C Kainate-binding, human cns receptors of the eaa3 family |
| 02/03/2005 | WO2005010524A1 Stem cell-based methods for identifying and characterizing agents |
| 02/03/2005 | WO2005010197A2 A systemic small rna signaling system in plants |
| 02/03/2005 | WO2005010191A1 Plant cell cycle genes and methods of use |
| 02/03/2005 | WO2005010173A2 Keratinocyte culturing method and the use thereof |
| 02/03/2005 | WO2005010172A2 Aligned scaffolds for improved myocardial regeneration |
| 02/03/2005 | WO2005010169A2 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 02/03/2005 | WO2005010162A2 Automated cell culture system and process |
| 02/03/2005 | WO2005010160A2 Liquid crystals with reduced toxicity and applications thereof |
| 02/03/2005 | WO2005010157A2 Use of pleiotrophin in the diagnosis, treatment and prevention of disease |
| 02/03/2005 | WO2005010151A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/03/2005 | WO2005010146A2 Adenoviral e1a/e1b complementing cell line |
| 02/03/2005 | WO2005010139A2 Ferromagnetic cell and tissue culture microcarriers |
| 02/03/2005 | WO2005010050A1 Hetero type pentamer recombinant vaccine |
| 02/03/2005 | WO2005010046A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 02/03/2005 | WO2005009497A1 Decellularized extracellular matrix of conditioned body tissues and uses thereof |
| 02/03/2005 | WO2005009477A1 Compositions and methods for treating cardiac dysfunction |
| 02/03/2005 | WO2005009466A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using alloreactive natural killer cells |
| 02/03/2005 | WO2005009465A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds |
| 02/03/2005 | WO2005009369A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/03/2005 | WO2005009366A2 Restoring vascular function |
| 02/03/2005 | WO2005009222A2 Method of determining sperm capacitation |
| 02/03/2005 | WO2005009119A1 Rat model of diabetic nephropathy |
| 02/03/2005 | WO2004105477A3 Method for cloning in the rat by nuclear transfer |
| 02/03/2005 | WO2004101808A3 Genomic and proteomic approaches for the development of cell culture medium |
| 02/03/2005 | WO2004101735A3 Method and device for culturing tissue |
| 02/03/2005 | WO2004100773A3 Diagnostic and therapeutic treatments related to mitochondrial disorders |
| 02/03/2005 | WO2004065564A3 Electromagnetic activation of gene expression and cell growth |
| 02/03/2005 | WO2004050855A3 Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
| 02/03/2005 | WO2004045527A3 Modulation of nima-related kinase 6 expression |
| 02/03/2005 | WO2004043990A3 Human stem cell materials and methods |
| 02/03/2005 | WO2004016777A8 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests |
| 02/03/2005 | WO2003094859A3 Epha2 monoclonal antibodies and methods of use thereof |
| 02/03/2005 | WO2003090515A3 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 02/03/2005 | WO2003081250A8 Novel compositions and methods in cancer associated with altered expression of prlr |
| 02/03/2005 | WO2003064606A3 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 02/03/2005 | WO2003037248A3 Fibrin nanoparticles and uses thereof |
| 02/03/2005 | WO2003022222A3 Antisense modulation of protein kinase r expression |
| 02/03/2005 | WO2002102235A3 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| 02/03/2005 | WO2001025401A3 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 02/03/2005 | US20050028232 Recombination polypeptide for use as gene transfer tool in plant genetic engineering; tissue engineering |